This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The landscape of aesthetic medicine is undergoing a remarkable transformation, fueled by cutting-edge technology that delivers safer, more effective, and minimally invasive solutions. Todays patients demand natural-looking results with little to no downtime, pushing practitioners to adopt innovative tools and techniques that meet these expectations.
Wobbly Clients: The Struggle is Real by Pivot Point Product Experience Senior Manager, Jason Russell If youre in the beauty industry, you know the struggle of working with those clients who just cant sit still. You find yourself chasing them around the chair, adjusting your stance every few minutes, and trying to keep your precision despite the movement.
In case you missed it, this week we had news about Arcutis sNDA for roflumilast in pediatric AD, the current clinical and aesthetic applications of snail mucin, positive results from the CHE delgocitinib trial in China, and more.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content